Coronary Artery Disease Screening, Treatment, and Follow-up

Primary Care - Clinics in Office Practice

Volumn 33, Issue 4, 2006, Pages 863-885

  Junnila, Jennifer L ^a   Runkle, Guy P ^b  

^a Army Medical Department Center and School   (United States)

^b MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOCHEMICAL MARKER; CALCIUM CHANNEL BLOCKING AGENT; CLOPIDOGREL; DIHYDROPYRIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FIBRINOGEN RECEPTOR ANTAGONIST; GEMFIBROZIL; ISOSORBIDE; NITRATE; NITRIC ACID DERIVATIVE; PERINDOPRIL; RAMIPRIL; SILDENAFIL; WARFARIN;

ALCOHOL CONSUMPTION; ALTERNATIVE MEDICINE; ANGIOCARDIOGRAPHY; ANTICOAGULANT THERAPY; CARDIAC PATIENT; CLINICAL TRIAL; CORONARY ARTERY DISEASE; DIABETIC PATIENT; DIAGNOSTIC IMAGING; DIET; DRUG DOSE TITRATION; DRUG MEGADOSE; ELECTROCARDIOGRAM; ELECTRON BEAM TOMOGRAPHY; EVIDENCE BASED MEDICINE; EXERCISE; EXERCISE TEST; FOLLOW UP; HEART REHABILITATION; HEART STRESS; HIGH RISK PATIENT; HUMAN; HYPERTENSION; LOW DRUG DOSE; MONOTHERAPY; PALLIATIVE THERAPY; PATIENT CARE; PATIENT COUNSELING; PATIENT MONITORING; PHYSICIAN; PREOPERATIVE EVALUATION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROBABILITY; REVASCULARIZATION; REVIEW; RISK MANAGEMENT; SAFETY; SCREENING TEST; SMOKING CESSATION; WEIGHT REDUCTION;

ADULT; AGED; ANTICOAGULANTS; ANTIHYPERTENSIVE AGENTS; ASPIRIN; CORONARY ARTERY BYPASS; CORONARY DISEASE; ELECTROCARDIOGRAPHY; EVIDENCE-BASED MEDICINE; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 33845448273     PISSN: 00954543     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pop.2006.09.011     Document Type: Review

References (97)

1. National Center for Health Statistics, Centers for Disease Control and Prevention, US Department of Health and Human Services. Fast stats A to Z: leading causes of death. Available at: http://www.cdc.gov/nchs/fastats/lcod.htm. Accessed December 12, 2005.
2. American Heart Association. Cardiovascular disease statistics. Available at: =http://www.americanheart.org/presenter.jhtml?identifier=4478. Accessed December 12, 2005.
3. Wackers F.J., Young L.H., Inzucchi S.E., et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care 27 8 (2004) 1954-1961
4. Gibbons R.J., Balady G.J., Bricker J.T., et al. ACC/AHA/2002 guidelines update for exercise testing: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 106 (2002) 1883-1892
5. Snow V., Barry P., Fihn S.D., et al. Evaluation of primary care patients with chronic stable angina: guidelines form the American College of Physicians. Ann Intern Med 141 7 (2004) 57-64
6. US Preventive Services Task Force. Screening for coronary heart disease: recommendation statement. Ann Intern Med 140 (2004) 569-572
7. USPSTF recommendations (USPSTF Task Force February 2004). Available at: http://www.ahrq.gov/clinic/uspstf/uspsacad.htm. Accessed December 10, 2005.
8. Diamond G.A., and Forrester J.S. Analysis of probability as an aid in the clinical diagnosis of coronary artery disease. N Engl J Med 300 (1979) 1350-1358
9. Gibbons RJ, Abrams J, Chatterjee K, et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for the Management of Patients With Chronic Stable Angina). Available at: www.acc.org. Accessed January 23, 2006.
10. Framingham heart study-based risk calculator. Available at: =http://hin.nhlbi.nih.gov/atpiii/calculator.asp?usertype=prof. Accessed January 19, 2006.
11. Executive Summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection. Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2386-2397
12. Coronary Artery Surgery Study (CASS). A randomized trial of coronary artery bypass surgery. Circulation 68 (1983) 939-950
13. Fowler-Brown A., Pignone M., Pletcher M., et al. Exercise tolerance testing to screen for coronary heart disease; a systematic review for the technical support for the US Preventive Services Task Force. Ann Intern Med 140 4 (2004) W9-W24
14. Gianrossi R., Detrano R., Mulvihill D., et al. Exercise-induced ST depression in the diagnosis of coronary artery disease: a meta-analysis. Circulation 80 (1989) 87-98
15. Sox H.C., Littenberg B., and Garber A.M. The role of exercise testing in screening for coronary artery disease. Ann Intern Med 110 (1989) 456-469
16. Mahenthiran J., Bangalore S., Yao S., et al. Comparison of prognostic value of stress echocardiography versus stress electrocardiography in patients with suspected coronary artery disease. Am J Cardiol 96 5 (2005) 628-634
17. Tsutsui J.M., Elhendy A., Anderson J.R., et al. Prognostic value of dobutamine stress myocardial contrast perfusion echocardiography. Circulation 112 (2005) 1444-1450
18. Geleijnse M.L., Elhendy A., Fioretti P.M., et al. Dobutamine stress myocardial perfusion imaging. J Am Coll Cardiol 36 7 (2001) 2017-2027
19. He Z.X., Hedrick T.D., Pratt C.M., et al. Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia. Circulation 101 (2000) 244-251
20. Pletcher M.J., Tice J.A., Pignone M., et al. Using the coronary artery calcium score to predict coronary heart disease events. Arch Intern Med 164 (2004) 1285-1292
21. O'Malley P.G., Greenberg B.A., and Taylor A.J. Cost-effectiveness of using electron beam computed tomography to identify patients at risk for clinical coronary artery disease. Am Heart J 148 (2004) 106-113
22. Pignone M., Fowler-Brown A., Pletcher M., et al. Screening for asymptomatic coronary artery disease. Systematic evidence review No 22 (2003), Agency for Healthcare Research and Quality, Rockville (MD). Available at: www.ahrq.gov/downloads/pub/prevent/pdfser/chdser.pdf
23. Bashore T.M., Bates E.R., Berger P.B., et al. American College of Cardiology/Society for Cardiac Angiography and Interventions clinical expert consensus document of cardiac catheterization laboratory standards. J Am Coll Cardiol 37 (2001) 2170-2214
24. Wang T.H., Larson M.G., Levy D., et al. Plasma natriuretic peptide levels and the risk of cardiovascular events and death. N Engl J Med 350 7 (2004) 655-663
25. Pai J.K., Psichon T., Ma J., et al. Inflammatory markers and the risk of coronary heart disease in men and women. N Engl J Med 351 25 (2004) 2599-2610
26. Wilson P.W. CDC/AHA workshop on markers of inflammation and cardiovascular disease: ability of inflammatory markers to predict disease in asymptomatic patients. Circulation 110 25 (2004) e568-e571
27. Rakhit D.J., Downey M., Jeffries L., et al. Screening for coronary artery disease in patients with diabetes: a Bayesian strategy of clinical risk evalution and exercise echocardiography. Am Heart J 150 (2005) 1074-1080
28. Elhendy A., Arruda A.M., Mahoney D.W., et al. Prognostic stratification of diabetic patients by exercise echocardiography. J Am Coll Cardiol 37 6 (2001) 155-157
29. Marwick T.H., Case C., Sawada S., et al. Use of stress echocardiography to predict mortality in patients with diabetes and known or suspected coronary artery disease. Diabetes Care 25 6 (2002) 1042-1048
30. Lee T.H. Use of exercise tolerance testing: AHA/ACC guidelines summary. In: Braunwald E., Zipes D.P., and Libby P. (Eds). Heart disease: a textbook of cardiovascular medicine (2001), WB Saunders, Philadelphia 101
31. Seto C.K. Preparticipation cardiovascular screening. Clin Sports Med 22 (2003) 23-35
32. AAFP recommendations for clinical preventive services. Available at: http://www.aafp.org/x24976.xml. Accessed January 23, 2006.
33. Siscovick D.S., Ekelund L.G., Johnson J.L., et al. Sensitivity of exercise electrocardiography for acute cardiac events during moderate and strenuous physical activity. The Lipid Research Clinics Coronary Primary Prevention Trial. Arch Intern Med 151 (1991) 325-330
34. Ashley E.A. Preoperative cardiac evaluation: mechanisms, assessment, and reduction of risk. Thorac Surg Clin 15 2 (2005) 263-275
35. AAFP summary of ACC/AHA guidelines for ambulatory ECG. Available at: http://www.aafp.org/afp/20000201/practice.html. Accessed January 23, 2006.
36. Antithrombotic Trialists' Collaboration. Collaborative metaanalysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324 (2002) 71-86
37. Berger J.S.R.M., Avanzini F., Pangrazzi I., et al. Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials. JAMA 295 (2006) 306-313
38. Hankey G.J.S.C., and Dunbabin D.W. Thienopyridines or aspirin to prevent stroke and other serious vascular events in patients at high risk of vascular disease? A systematic review of the evidence from randomized trials. Stroke 31 (2000) 1779-1784
39. Stein P.D., Holger J., Schünemann, et al. Antithrombotic therapy in patients with saphenous vein and internal mammary artery bypass grafts: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126 Suppl 3 (2004) 600s-608s
40. Anaud S.Y.S. Oral anticoagulant therapy in patients with coronary artery disease: a metaanalysis. JAMA 282 (1999) 2058-2067
41. Heeschen C., and Hamm C. Difficulties with oral platelet glycoprotein IIb/IIIa receptor antagonists. Lancet 355 9201 (2000) 330-331
42. Gould A.L.R.J., Santanello N.C., Heyse J.F., et al. Cholesterol reduction yields clinical benefit: impact of statin trials. Circulation 97 (1998) 946-952
43. Sacks F.M., Pfeffer M.A., Moye L.A., et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Choleterol and Recurrent Events Trial investigators. N Engl J Med 335 (1996) 1001-1009
44. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 339 (1998) 1349-1357
45. Grundy S.M., Cleeman J., Merz C.N., et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines. Circulation 110 (2004) 227-239
46. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 9326 (2002) 7-22
47. Rubins H.B., Robins S.J., Collins D., et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. N Engl J Med 341 6 (1999) 410-418
48. Israel D.H., and Gorlin R. Fish oils in the prevention of atherosclerosis. J Am Coll Cardiol 19 1 (1992) 174-185
49. Burr M., Fehily A., Gilbert J., et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: Diet and Reinfarction Trial (DART). Lancet 2 8666 (1989) 757-761
50. O'Connor G.T., Malenka D.J., Olmstead E.M., et al. A meta-analysis of randomized trials of fish oil in prevention of restenosis following coronary angioplasty. Am J Prev Med 8 3 (1992) 186-192
51. National High Blood Pressure Education Program. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: National Institutes of Health, National Heart, Lung, and Blood Institute, National High Blood Pressure Education Program. NIH Publication No. 04-5230 (2004), National Institutes of Health, Bethesda (MD)
52. The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. N Engl J Med 342 3 (2000) 145-153
53. Fox K., and European Trial On Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362 9386 (2003) 78-8
54. van der Heuvel A.F., Dunselman P., Kingma T., et al. Reduction of exercise-induced myocardial ischemia during add-on treatment with the angiotensin-converting enzyme inhibitor enalapril in patients with normal left ventricular function and optimal beta blockade. J Am Coll Cardiol 37 2 (2001) 470-474
55. Furberg C.D., Psaty B.M., and Meyer J.V. Nifedipine: dose-related increase in mortality in patients with coronary heart disease. Circulation 92 (1995) 1326-1331
56. Yusuf S., Zucker D., Peduzzi P., et al. Effect of coronary artery bypass graft surgery on survival: overview of 10-year results from randomised trials by the Coronary Artery Bypass Graft Surgery Trialists Collaboration. Lancet 344 8922 (1994) 563-570
57. Cameron A., Davis K., Green G., et al. Coronary bypass surgery with internal-thoracic-artery grafts-effects on survival over a 15-year period. N Engl J Med 334 4 (1996) 216-219
58. Bucher H., Hengstler P., Schindler C., et al. Percutaneous transluminal coronary angioplasty versus medical treatment for non-acute coronary heart disease: meta-analysis of randomised controlled trials. BMJ 321 7253 (2000) 73-77
59. Rita-2 trial participants. Coronary angioplasty verses medical therapy for angina: the second Randomised Intervention Treatment of Angina (RITA-2) trial. Lancet 350 (1997) 461-468
60. Davies R., Goldberg A., Forman S., et al. Asymptomatic Cardiac Ischemia Pilot (ACIP) study two-year follow-up: outcomes of patients randomized to initial strategies of medical therapy versus revascularization. Circulation 95 8 (1997) 2037-2043
61. Sharaf B., Williams D., Miele N., et al. A detailed angiographic analysis of patients with ambulatory electrocardiographic ischemia: results from the Asymptomatic Cardiac Ischemia Pilot (ACIP) study angiographic core laboratory. J Am Coll Cardiol 29 1 (1997) 78-84
62. Pitt B WD, Brown WV, van Boven AJ, et al. Aggressive lipid lowering therapy compared with angioplasty in stable coronary artery disease. N Engl J Med 1999;341(2):70-86.
63. Frye R.L., and The BARI investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med 335 4 (1996) 217-225
64. The BARI investigators. Seven-year outcome in the Bypass Angioplasty Revascularization Investigation (BARI) by treatment and diabetic status. J Am Coll Cardiol 35 5 (2000) 1122-1129
65. Hueb W.A., Soares P.R., Oliveira Sr. A.D., et al. Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS): a prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending coronary artery stenosis. Circulation 100 Suppl II (1999) II-107-II-113
66. Serruys P., Unger F., Sousa J., et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 344 15 (2001) 1117-1124
67. McBride P. The health consequences of smoking. Cardiovascular diseases. Med Clin North Am 76 2 (1992) 333-353
68. CDC. The health benefits of smoking cessation: a report of the Surgeon General. Rockville (MD): US Department of Health and Human Services, Public Health Service, 1990. DHHS publication number (CDC) 90-8416.
69. Mulcahy R., Hickey N., Graham I., et al. Factors affecting the 5 year survival rate of men following acute coronary heart disease. Am Heart J 93 5 (1977) 556-559
70. Vlietstra R., Kronmal R., Oberman A., et al. Effect of cigarette smoking on survival of patients with angiographically documented coronary artery disease. Report from the CASS registry. JAMA 255 8 (1986) 1023-1027
71. Hubert H.B., Feinleib M., McNamara P.M., et al. Obesity as an independent risk factor for cardiovascular disease: a 26-year follow-up of participants in the Framingham Heart Study. Circulation 67 5 (1983) 968-977
72. Leon A.S., and Sanchez O.A. Response of blood lipids to exercise training alone or combined with dietary intervention. Med Sci Sports Exerc 33 (2001) S502-S515
73. Fagard R.H. Exercise characteristics and the blood pressure response to dynamic physical training. Med Sci Sports Exerc 33 (2001) S484-S492
74. Fletcher G.F., Balady G., Blair S.N., et al. Statement on exercise: benefits and recommendations for physical activity programs for all americans: a statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation 94 (1996) 857-862
75. Jolliffe JA, Rees K, Taylor RS, et al. Exercise-based rehabilitation for coronary heart disease. Cochrane Database Syst Rev 2001;1:CD001800.
76. Thompson P.D., Buchner D., Piña I.L., et al. Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity). Circulation 107 (2003) 3109-3116
77. AHCPR. Cardiac rehabilitation. Agency for Health Care Policy and Research. Available at: =http://www.ncbi.nlm.nih.gov/books/bv.fcgi?rid=hstat2.chapter.6677. Accessed January 23, 2006.
78. Lewis B., and Lynch W. The effect of physician advice on exercise behavior. Prev Med 22 1 (1993) 110-121
79. Hootman J.M., Macera C.A., Ainsworth B.E., et al. Epidemiology of musculoskeletal injuries among sedentary and physically active adults. Med Sci Sports Exerc 34 5 (2002) 838-844
80. Friedman M., Thoresen C., Gill J., et al. Alteration of type A behavior and its effect on cardiac recurrences in post myocardial infarction patients: summary results of the recurrent coronary prevention project. Am Heart J 112 4 (1986) 653-665
81. Yano K., Rhoads G., and Kagan A. Coffee, alcohol and risk of coronary heart disease among Japanese men living in Hawaii. N Engl J Med 297 8 (1977) 405-409
82. Stampfer M., Colditz G., Willett W., et al. A prospective study of moderate alcohol consumption and the risk of coronary disease and stroke in women. N Engl J Med 319 5 (1988) 267-273
83. Gaziano J., Buring J., Breslow J., et al. Moderate alcohol intake, increased levels of high-density lipoprotein and its subfractions, and decreased risk of myocardial infarction. N Engl J Med 329 25 (1993) 1829-1834
84. Murchie P.C.N., Ritchie L.D., Simpson J.A., et al. Secondary prevention clinics for coronary heart disease: four year follow up of a randomised controlled trial in primary care. BMJ 326 7380 (2003) 84
85. Hautvast R., DeJongste M., Staal M., et al. Spinal cord stimulation in chronic intractable angina pectoris: a randomized, controlled efficacy study. Am Heart J 136 6 (1998) 1114-1120
86. Ekre O., Eliasson T., Norrsell H., et al. Long-term effects of spinal cord stimulation and coronary artery bypass grafting on quality of life and survival in the ESBY study. Eur Heart J 23 (2002) 1938-1945
87. Arora R., Chou T., Jain D., et al. The Multicenter Study of Enhanced External Counterpulsation (MUST-EECP): effect of EECP on exercise-induced myocardial ischemia and anginal episodes. J Am Coll Cardiol 33 7 (1999) 1833-1840
88. Allen K., Dowling R., Fudge T., et al. Comparison of transmyocardial revascularization with medical therapy in patients with refractory angina. N Engl J Med 341 14 (1999) 1029-1036
89. Burkhoff D., Schmidt S., Schulman S., et al. Transmyocardial laser revascularisation compared with continued medical therapy for treatment of refractory angina pectoris: a prospective randomised trial. ATLANTIC Investigators. Angina treatments-lasers and normal therapies in comparison. Lancet 354 9182 (1999) 885-890
90. Aaberge L., Nordstrand K., Dragsund M., et al. Transmyocardial revascularization with CO2 laser in patients with refractory angina pectoris. Clinical results from the Norwegian randomized trial. J Am Coll Cardiol 35 5 (2000) 1170-1177
91. Schofield P., Sharples L., Caine N., et al. Transmyocardial laser revascularisation in patients with refractory angina: a randomised controlled trial. Lancet 353 9152 (1999) 519-524
92. Oesterle S., Sanborn T., Ali N., et al. Percutaneous transmyocardial laser revascularisation for severe angina: the PACIFIC randomised trial. Potential class improvement from intramyocardial channels. Lancet 356 9243 (2000) 1705-1710
93. Snow V., Barry P., Fihn S.D., et al. Primary care management of chronic stable angina and asymptomatic suspected or known coronary artery disease: a clinical practice guideline from the American College of Physicians. Ann Intern Med 141 (2004) 562-567
94. American College of Radiology (ACR), Expert Panel on Thoracic Imaging. Congestive heart failure (2003), American College of Radiology (ACR), Reston (VA) p. 4
95. Talreja D., Gruver C., Sklenar J., et al. Efficient utilization of echocardiography for the assessment of left ventricular systolic function. Am Heart J 139 (2000) 394-398
96. Mark D.B., Hlatky M.A., Harrell Jr. F.E., et al. Exercise treadmill score for predicting prognosis in coronary artery disease. Ann Intern Med 106 6 (1987) 793-800
97. Finnish Medical Society Duodecim. Coronary angiography and indications for CABG or angioplasty. EBM guidelines. Evidence-based medicine [CD-ROM] (2004), Duodecim Medical Publications Ltd, Helsinki (Finland). Available at: http://www.guidelines.gov/summary/summary.aspx?ss=15&doc_id=8811 &nbr=4857 (accessed 23 Jan 2006)